Differences in Distribution and Detection Rate of the [<sup>68</sup>Ga]Ga-PSMA Ligands PSMA-617, -I&T and -11—Inter-Individual Comparison in Patients with Biochemical Relapse of Prostate Cancer

Differences in Distribution and Detection Rate of the [<sup>68</sup>Ga]Ga-PSMA Ligands PSMA-617, -I&T and -11—Inter-Individual Comparison in Patients with Biochemical Relapse of Prostate Cancer

The biochemical relapse of prostate cancer is diagnostically challenging but of high clinical impact for subsequent patient treatment. PET/CT with radiolabeled PSMA ligands outperforms conventional diagnostic methods in the detection of tumor recurrence. Several radiopharmaceuticals were and are ava...

Full description

Bibliographic Details
Main Authors: Falk Gühne, Stefanie Radke, Thomas Winkens, Christian Kühnel, Julia Greiser, Philipp Seifert, Robert Drescher, Martin Freesmeyer
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pharmaceuticals
Subjects:
PSMA
PET/CT
prostate cancer
biochemical relapse
<sup>68</sup>Gallium
Online Access:https://www.mdpi.com/1424-8247/15/1/9

Internet

https://www.mdpi.com/1424-8247/15/1/9

Similar Items